Strategies, Tools & Talent for What’s Next! In our final session of the series, we’ll focus on setting your organization – and your career – up for success in the year ahead. We’ll discuss how compliance drives business impact, how…
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations…